Business Insider: "Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology."

We were honored to be included in a recent Business Insider article on how technology companies are working to diversify clinical trials – and what else needs to be done. 

"The pandemic's disproportionate effect on racial and ethnic minorities highlighted the lack of diversity in clinical trials for drug and vaccine developers — and tech companies are rushing to help them reach more diverse participants..."

Read more here